These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 18848663)

  • 1. Melanoma affinity in mice and immunosuppressed sheep of [(125)I]N-(4-dipropylaminobutyl)-4-iodobenzamide, a new targeting agent.
    Labarre P; Papon J; Rose AH; Guerquin-Kern JL; Morandeau L; Wu TD; Moreau MF; Bayle M; Chezal JM; Croisy A; Madelmont JC; Turner H; Moins N
    Nucl Med Biol; 2008 Oct; 35(7):783-91. PubMed ID: 18848663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of I-BZA (N-2-diethylaminoethyl-4-iodobenzamide) in grafted melanoma and normal skin: a study by secondary ion mass spectroscopy.
    Chehade F; De Labriolle-Vaylet C; Michelot J; Moins N; Moreau MF; Hindié E; Papon J; Escaig F; Galle P; Veyre A
    Cell Mol Biol (Noisy-le-grand); 2001 May; 47(3):529-34. PubMed ID: 11441960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uptake in melanoma cells of N-(2-diethylaminoethyl)-2-iodobenzamide (BZA2), an imaging agent for melanoma staging: relation to pigmentation.
    Mansard S; Papon J; Moreau MF; Miot-Noirault E; Labarre P; Bayle M; Veyre A; Madelmont JC; Moins N
    Nucl Med Biol; 2005 Jul; 32(5):451-8. PubMed ID: 15982575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, in vitro binding and biodistribution in B16 melanoma-bearing mice of new iodine-125 spermidine benzamide derivatives.
    Moreau MF; Papon J; Labarre P; Moins N; Borel M; Bayle M; Bouchon B; Madelmont JC
    Nucl Med Biol; 2005 May; 32(4):377-84. PubMed ID: 15878507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and preliminary biological evaluation of acridine compounds as potential agents for a combined targeted chemo-radionuclide therapy approach to melanoma.
    Desbois N; Gardette M; Papon J; Labarre P; Maisonial A; Auzeloux P; Lartigue C; Bouchon B; Debiton E; Blache Y; Chavignon O; Teulade JC; Maublant J; Madelmont JC; Moins N; Chezal JM
    Bioorg Med Chem; 2008 Aug; 16(16):7671-90. PubMed ID: 18656367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-targeting properties of 90Y- and 177Lu-labeled alpha-melanocyte stimulating hormone peptide analogues in a murine melanoma model.
    Miao Y; Hoffman TJ; Quinn TP
    Nucl Med Biol; 2005 Jul; 32(5):485-93. PubMed ID: 15982579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of N-(2-diethylaminoethyl)4-iodobenzamide in the pigmented mouse eye: a microanalytical study.
    Chehade F; Michelot J; Hindié E; Papon J; Delabriolle-Vaylet C; Zhang L; Escaig F; Moreau MF; Veyre A
    Cell Mol Biol (Noisy-le-grand); 1996 May; 42(3):343-50. PubMed ID: 8793189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of iodine-123-IMBA for melanoma imaging.
    Nicholl C; Mohammed A; Hull WE; Bubeck B; Eisenhut M
    J Nucl Med; 1997 Jan; 38(1):127-33. PubMed ID: 8998166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, characterization and comparative biodistribution study of a new series of p-iodine-125 benzamides as potential melanoma imaging agents.
    Moins N; Papon J; Seguin H; Gardette D; Moreau MF; Labarre P; Bayle M; Michelot J; Gramain JC; Madelmont JC; Veyre A
    Nucl Med Biol; 2001 Oct; 28(7):799-808. PubMed ID: 11578901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of radiolabeled (hetero)aromatic analogues of N-(2-diethylaminoethyl)-4-iodobenzamide for imaging and targeted radionuclide therapy of melanoma.
    Chezal JM; Papon J; Labarre P; Lartigue C; Galmier MJ; Decombat C; Chavignon O; Maublant J; Teulade JC; Madelmont JC; Moins N
    J Med Chem; 2008 Jun; 51(11):3133-44. PubMed ID: 18481842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary ion mass spectrometry as a tool for investigating radiopharmaceutical distribution at the cellular level: the example of I-BZA and (14)C-I-BZA.
    Chéhadé F; de Labriolle-Vaylet C; Moins N; Moreau MF; Papon J; Labarre P; Galle P; Veyre A; Hindié E
    J Nucl Med; 2005 Oct; 46(10):1701-6. PubMed ID: 16204721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted radionuclide therapy of melanoma: anti-tumoural efficacy studies of a new 131I labelled potential agent.
    Bonnet-Duquennoy M; Papon J; Mishellany F; Labarre P; Guerquin-Kern JL; Wu TD; Gardette M; Maublant J; Penault-Llorca F; Miot-Noirault E; Cayre A; Madelmont JC; Chezal JM; Moins N
    Int J Cancer; 2009 Aug; 125(3):708-16. PubMed ID: 19437532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational model predicts effective delivery of 188-Re-labeled melanin-binding antibody to metastatic melanoma tumors with wide range of melanin concentrations.
    Schweitzer AD; Rakesh V; Revskaya E; Datta A; Casadevall A; Dadachova E
    Melanoma Res; 2007 Oct; 17(5):291-303. PubMed ID: 17885584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of novel radioiodinated benzamides for malignant melanoma.
    Pham TQ; Greguric I; Liu X; Berghofer P; Ballantyne P; Chapman J; Mattner F; Dikic B; Jackson T; Loc'h C; Katsifis A
    J Med Chem; 2007 Jul; 50(15):3561-72. PubMed ID: 17602544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-melanoma efficacy of internal radionuclide therapy in relation to melanin target distribution.
    Bonnet M; Mishellany F; Papon J; Cayre A; Penault-Llorca F; Madelmont JC; Miot-Noirault E; Chezal JM; Moins N
    Pigment Cell Melanoma Res; 2010 Oct; 23(5):e1-11. PubMed ID: 20444199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and characterization of a novel Al(18)F-NOTA-BZA conjugate for melanin-targeted imaging of malignant melanoma.
    Chang CC; Chang CH; Lo YH; Lin MH; Shen CC; Liu RS; Wang HE; Chen CL
    Bioorg Med Chem Lett; 2016 Aug; 26(16):4133-9. PubMed ID: 27445169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and preliminary biological studies of the novel conjugate 188Re-labeled meso-tetrakis(4-sulfophenyl)porphyrin in mice.
    Jia Z; Deng H; Pu M
    Nucl Med Biol; 2007 Aug; 34(6):643-9. PubMed ID: 17707804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of novel radioiodinated nicotinamides for malignant melanoma.
    Liu X; Pham TQ; Berghofer P; Chapman J; Greguric I; Mitchell P; Mattner F; Loc'h C; Katsifis A
    Nucl Med Biol; 2008 Oct; 35(7):769-81. PubMed ID: 18848662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultra-structural cell distribution of the melanoma marker iodobenzamide: improved potentiality of SIMS imaging in life sciences.
    Guerquin-Kern JL; Hillion F; Madelmont JC; Labarre P; Papon J; Croisy A
    Biomed Eng Online; 2004 Apr; 3():10. PubMed ID: 15068483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of ¹²³/¹³¹I-Iochlonicotinamide as a novel SPECT probe for malignant melanoma.
    Chang CC; Chang CH; Shen CC; Chen CL; Liu RS; Lin MH; Wang HE
    Bioorg Med Chem; 2015 May; 23(9):2261-9. PubMed ID: 25800432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.